Roche Finalizes Poseida Acquisition: This Cell Therapy Deal Feels Like A Win/Win
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Yahoo Finance23h
RH (RH)
Insiders were net buyers of RH's ( NYSE:RH ) stock during the past year. That is, insiders bought more stock than they... CORTE MADERA, Calif., December 18, 2024--RH (NYSE: RH) announced today the ...